HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$47.51
Day range
$46.79 - $47.97
Year range
$5.65 - $65.60
Market cap
2.44B USD
Avg Volume
983.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.25M | -38.87% |
Operating expense | 7.34M | 13.60% |
Net income | -14.76M | 15.46% |
Net profit margin | -1.18K | -38.29% |
Earnings per share | -0.30 | 28.57% |
EBITDA | -19.63M | 1.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 651.76M | 105.68% |
Total assets | 688.98M | 95.20% |
Total liabilities | 33.22M | -20.32% |
Total equity | 655.76M | — |
Shares outstanding | 51.84M | — |
Price to book | 3.76 | — |
Return on assets | -9.43% | — |
Return on capital | -9.61% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -14.76M | 15.46% |
Cash from operations | -14.84M | -6.66% |
Cash from investing | -113.74M | -1,201.33% |
Cash from financing | 322.17M | 20,290.57% |
Net change in cash | 193.60M | 1,018.79% |
Free cash flow | -10.81M | -51.80% |
About
Founded
2017
Website
Employees
68